Strides Pharma's OneSource raises Rs 801 crore in pre-listing round

OneSource Specialty Pharma, an associate of Strides Pharma, secured Rs. 801 crore from investors including HBM Healthcare Investments and WhiteOak Capital. With these funds, OneSource will reduce debt and enhance its manufacturing capabilities. The company aims to list its shares by March 2025 and targets being debt-free by FY26. Strides shareholders will benefit significantly from this transaction.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/MIlZQHG
via IFTTT